Genix Pharmaceuticals Corp (GENX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2019 | 10-2018 | 10-2017 | 10-2016 | 10-2015 | |
| Sales | 137 | 420 | 1,011 | 925 | 651 |
| Cost of Goods | 183 | 327 | 511 | 513 | 487 |
| Gross Profit | -46 | 93 | 499 | 411 | 163 |
| Operating Expenses | 98 | 118 | 765 | 535 | 691 |
| Operating Income | -143 | -25 | -266 | -123 | -527 |
| Interest Expense | N/A | 0 | N/A | 16 | 1 |
| Other Income | -21 | 0 | 23 | 11 | -18 |
| Pre-tax Income | -165 | -25 | -243 | -129 | -546 |
| Net Income Continuous | -165 | -25 | -243 | -129 | -546 |
| Net Income Discontinuous | 0 | 159 | N/A | N/A | N/A |
| Net Income | $-165 | $134 | $-243 | $-129 | $-546 |
| EPS Basic Total Ops | 0.00 | 0.00 | -0.01 | 0.00 | -0.02 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | -0.01 | 0.00 | -0.02 |
| EPS Diluted Total Ops | 0.00 | 0.00 | -0.01 | 0.00 | -0.02 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | -0.01 | 0.00 | -0.02 |
| EBITDA(a) | $-143 | $-25 | $-224 | $-67 | $-496 |